[Assisted reproductive technique for an opiates dependant couple]

Area of Science:

• Obstetrics and Gynecology
• Addiction Medicine
• Reproductive Endocrinology

Context:

• Opioid-addicted pregnant women face significant challenges in achieving healthy pregnancies and stable family environments.
• Substance use disorders in pregnancy necessitate specialized, multidisciplinary care approaches.
• Existing healthcare systems may present barriers to parental stabilization and assisted reproductive technologies for affected couples.

Purpose:

• To describe the integrated care model of the "Motherhood and Addiction Alsace" network for opioid-addicted pregnant women.
• To highlight the successful application of assisted reproductive technology (in vitro fertilization) within this network for a couple with opioid use disorder and chronic hepatitis.
• To discuss the complexities of parental substance use, pain management, neonatal care, and interprofessional collaboration in this population.

Summary:

• The "Motherhood and Addiction Alsace" network provides comprehensive care for pregnant women with opioid addiction, focusing on maternal health, fetal well-being, and parental stabilization.
• A case involving a couple on methadone treatment, with the husband having chronic hepatitis, successfully accessed in vitro fertilization services through the network.
• The case illustrates the network's capacity to address challenges in parenthood, including appropriate pain management, neonatal care, and coordinated multidisciplinary professional action.

Impact:

• Demonstrates the feasibility and benefit of specialized networks in managing complex pregnancies complicated by substance use disorders.
• Highlights the potential for assisted reproductive technologies to support parenthood goals for couples affected by addiction.
• Emphasizes the critical role of coordinated healthcare professional action in improving outcomes for both mother and child.